Sign In

Edward Likovich, PhD

CEO @ Nymbl

Dr. Edward Likovich is a technology startup executive renowned for his expertise in hardware and software commercialization, product design, business strategy, and fundraising. With a strong academic background, including a PhD and SM in Applied Physics from Harvard University, as well as an AB with High Honors in Physics, Dr. Likovich possesses a formidable skill set honed through extensive experience.

Having served in key leadership roles at various organizations, Dr. Likovich has made significant contributions. He notably held the position of CEO at Nymbl Science, Managing Partner at Shenango Labs, and Board Chair at Girls Athletic Leadership School, among others. His diverse professional journey includes stints as an Entrepreneur in Residence at Meritage Funds, Chief Executive Officer at GoodLux Technology, and Associate at J.P. Morgan, further showcasing his versatility and adaptability.

Dr. Likovich's commitment to fostering talent is evident through his roles as an Assistant Head Teaching Fellow and Senior Resident Tutor at Harvard University, reflecting his dedication to education and mentorship. His tenure as a Graduate Student Physics Researcher underscores his profound understanding of scientific research and innovation.

Embodying a passion for problem-solving and team building, Dr. Edward Likovich continues to make a mark in the technology industry, driven by a mission to create impactful solutions and drive organizational success.

Highlights

Aug 14 · linkedin

At Nymbl, we're redefining how we approach fall risk - a problem that's as significant as chronic conditions like CHF and diabetes, yet often overlooked. Falls aren't just accidents; they're an invisible epidemic impacting millions of older adults, with consequences that ripple through our healthcare system.

We've pioneered a cutting-edge methodology to uncover the true cost of falls for Medicare Advantage plans. By meticulously analyzing ICD-10 codes and applying them to real-world data, we've enhanced the accuracy of identifying fall-related medical claims by over 60%.

The findings? A staggering average fall prevalence rate of 21% in a normative Medicare Advantage population over three years. This isn't just data - it's a call to action.

Interested in learning more? Download our exclusive whitepaper below.

#HealthcareInnovation #FallPrevention #MedicareAdvantage #PopulationHealth #Nymbl

Jun 5 · linkedin

Falls: A Chronic Condition and The Invisible Epidemic - Here’s Why:

When we think about chronic conditions that incur high healthcare costs, diabetes, vascular disease, and heart failure typically come to mind.

However, the data reveals a shocking and often overlooked reality: falls incur a higher average annual cost per member, even surpassing conditions like congestive heart failure and chronic obstructive pulmonary disease (COPD).

Average Annual Cost Per Person by Chronic Condition: Diabetes with Chronic Complications: $25,337 Vascular Disease: $29,737 Chronic Obstructive Pulmonary Disease: $31,014 Congestive Heart Failure: $37,382 Falls: $37,734

Falls ARE the invisible epidemic in our healthcare system. They are common with profound and far-reaching impact, leading to severe injuries, long-term disabilities, and significant healthcare expenditures.

It's time to finally address this crisis with the attention and resources it deserves. By investing in fall prevention, we can reduce the human and financial toll of this invisible epidemic.

Edward Likovich, PhD
Add to my network

Location

Denver Metropolitan Area